Finger clip could reveal hidden heart risks in men with ED

NCT ID NCT06720597

Recruiting now Knowledge-focused Sponsor: University of California, Irvine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a simple finger device called EndoPAT can measure blood vessel function in men aged 30–50 with erectile dysfunction or low testosterone. About 120 men will use the device before and after taking daily low-dose ED medication or testosterone therapy. The goal is to see if the device can track improvements in blood vessel health over 3 to 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: daily low-dose PDE5 inhibitor or testosterone therapy
What this could lead to: If successful, this could show that the EndoPAT device is a useful tool for tracking blood vessel health in men with erectile dysfunction or low testosterone.
What could go wrong: This is an early, small, non-randomized study with no control group, so results may not be conclusive or widely applicable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOTHELIAL DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction eunuchism hypogonadism hypogonadism, male

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOTHELIAL DYSFUNCTION ERECTILE DYSFUNCTION HYPOGONADISM, MALE

Contacts and locations

Locations

UCI Urology | Men's Health Center
RECRUITING

Newport Beach, California, 92660, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.